PAKOLA STEVE (Chief Medical Officer) sold 2.0% of their position (5.12K shares) of REGENXBIO INC. on the open market
Open‑market sale worth $53.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/12/2026ACC: 0001700659-26-000008
Officer· Chief Medical Officer
Since Apr 2019
-5.12K
Net shares
Net seller
$53.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.12K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.12K
Price / share
$10.35
Trade value
$53.03K
% of position
2.0%
3/10/2026
253.05K→247.93K
Total
Net shares
−5.12K
Net value
-$53.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/10/2026 | S · Sale | −5.12K | $10.35 | $53.03K | 2.0% | 253.05K | 247.93K |
| Total | −5.12K | -$53.03K | ||||||
Derivative Transactions0
No derivative transactions reported